000520 — Samil Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Market Cap
KR₩170bn
Enterprise Value
KR₩323bn
Revenue
KR₩196bn

Annual balance sheet for Samil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,772	17,214	15,261	1,966	929
Net Total Accounts Receivable
Net Total Receivables	26,273	30,195	31,374	34,304	35,900
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	79,200	72,523	76,711	74,781	81,115
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	71,902	64,808	103,394	233,946	242,198
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	183,875	191,661	226,405	356,700	370,680
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	68,156	98,684	121,674	132,592	168,675
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	121,602	128,110	160,658	230,881	242,853
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	62,272	63,551	65,746	125,820	127,827
Total Liabilities & Shareholders' Equity	183,875	191,661	226,405	356,700	370,680
Total Common Shares Outstanding